Softgel capsule market expected to reach $2.07 billion by 2032 with 6.17% CAGR
From GlobeNewswire: 2025-01-14 08:28:00
The Softgel Capsule Market was valued at USD 1.21 billion in 2023, expected to reach USD 2.07 billion by 2032, with a CAGR of 6.17%. Growing demand for health supplements and vegan alternatives is driving market growth, with softgel capsules offering enhanced bioavailability and ease of consumption for various nutrients.
The global softgel capsule market has seen substantial growth due to consumer preference for easy-to-consume dietary supplements. Softgel capsules offer improved absorption and are increasingly used in drug delivery systems. The market is driven by demand in the vitamins and dietary supplements segment, with a rising trend towards plant-based formulations.
In 2023, gelatin-based softgel capsules dominated the market, holding over 60% share due to cost-effectiveness and stability. Gelatin capsules are widely used in pharmaceutical and nutraceutical industries. The Vitamins and Dietary Supplements segment led the market, with a 32.3% share, driven by demand for fat-soluble vitamins like Vitamin D and Omega-3 fatty acids.
Major players in the Softgel Capsule Market include Fuji Capsule, CAPTEK Softgel International, and Lonza Capsules & Health Ingredients. In recent developments, Caplin Point Laboratories received INVIMA approval, while Lee Health launched natural heart care capsules. North America holds the largest market share, driven by demand for dietary supplements and nutraceuticals. The United States is a major market for health supplements, driving growth in the softgel capsule market. The Asia Pacific region, especially China and India, will see the highest growth due to increasing demand for vitamins and wellness products. In 2023, 10% of the global population over 65 used softgel capsules, with vegan options growing by 12% annually.
Statistics show that vegan and plant-based softgel consumption increased by 12% in 2023, with Europe and North America leading the demand. Softgel capsules made up 25% of oral drug delivery systems in 2023, favored for their bioavailability and patient compliance. A report on the market’s analysis and outlook from 2024-2032 is available for purchase.
The report includes sections on market dynamics, statistical insights, trends, competitive landscape, and regional analysis. With a focus on health conditions, prescription trends, production, consumption volume, and healthcare spending, the report provides valuable information for manufacturers and consumers. SNS Insider offers comprehensive market research and consulting services globally.
Read more at GlobeNewswire: Softgel Capsule Market Size to Hit USD 2.07 Billion by